Jop Kind received his PhD from the Radboud University Nijmegen in 2008 for his work on chromatin and gene expression in the research group of Asifa Akhtar at EMBL Heidelberg. He subsequently joined the lab of Bas van Steensel at The Netherlands Cancer Institute for his postdoctoral training, where he further studied chromatin and developed techniques to explore nuclear organization in single cells. For this work he received EMBO/LTF and NWO/Veni fellowships. In October 2014, he became a group leader at the Hubrecht Institute and was awarded an ERC Starting and a NWO Vidi grant. In 2016 he was honored with the prestigious Antoni van Leeuwenhoek (NKI) and John Kendrew awards (EMBL).
- 2016: Sir John Kendrew Award
- 2015: Antoni van Leeuwenhoek Award
- Kind, J., & Akhtar, A. (2007). Cotranscriptional recruitment of the dosage compensation complex to X-linked target genes. Genes & development, 21(16), 2030-2040.
- Kind, J., Pagie, L., de Vries, S. S., Nahidiazar, L., Dey, S. S., Bienko, M., ... & Fudenberg, G. (2015). Genome-wide maps of nuclear lamina interactions in single human cells. Cell, 163(1), 134-147.
- Kind, J., Pagie, L., Ortabozkoyun, H., Boyle, S., de Vries, S. S., Janssen, H., ... & van Steensel, B. (2013). Single-cell dynamics of genome-nuclear lamina interactions. Cell, 153(1), 178-192.
- Kind, J., & Van Steensel, B. (2010). Genome–nuclear lamina interactions and gene regulation. Current opinion in cell biology, 22(3), 320-325.
- Kind, J., Vaquerizas, J. M., Gebhardt, P., Gentzel, M., Luscombe, N. M., Bertone, P., & Akhtar, A. (2008). Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell, 133(5), 813-828.